Form 4: USANA Health Sciences Director Acquires Shares

USANA Health Sciences Director John Turman Fleming acquired 2,450 shares of common stock on June 1, 2026, for $17.93 per share.

Summary

• John Turman Fleming, a Director at USANA Health Sciences Inc., acquired 2,450 shares of common stock.
• The transaction occurred on June 1, 2026.
• The purchase price was $17.93 per share.
• Following this transaction, Fleming beneficially owns 4,230 shares of common stock directly.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a moderately positive filing due to a director's direct investment, signaling confidence, though it lacks broader financial performance data.

Positives

• Director's investment in the company's stock, indicating confidence in its future prospects.

Future Outlook

No specific forward-looking statements or guidance were provided in this filing.

Industry Context

StockSavvy.ai notes that insider stock purchases by directors can be interpreted as a positive signal of management's belief in the company's valuation and future performance within the competitive health sciences industry.

Stakeholder Impact

• Shareholders may view the director's purchase as a positive indicator of confidence in the company's future.

Key Dates

Keywords

USANA Health Sciences, USNA, Form 4, Insider Trading, Stock Acquisition, Director Transaction, Beneficial Ownership